Mirum Pharmaceuticals (MIRM)
(Real Time Quote from BATS)
$39.14 USD
-0.35 (-0.89%)
Updated Jul 22, 2024 01:02 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.48 |
EPS Last Quarter | -0.54 |
Last EPS Surprise | -35.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.66 |
Next Year | -0.45 |
EPS (TTM) | -2.69 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 74.57M | 80.51M | 311.69M | 405.88M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 75.60M | 82.03M | 315.99M | 482.83M |
Low Estimate | 73.20M | 79.34M | 306.80M | 377.46M |
Year ago Sales | 37.50M | 47.73M | 186.37M | 311.69M |
Year over Year Growth Est. | 98.86% | 68.67% | 67.24% | 30.22% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.48 | -0.37 | -1.66 | -0.45 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.36 | -0.30 | -1.29 | -0.44 |
High Estimate | -0.36 | -0.30 | -1.23 | 1.79 |
Low Estimate | -0.57 | -0.46 | -2.06 | -2.06 |
Year ago EPS | -0.92 | -0.57 | -3.94 | -1.66 |
Year over Year Growth Est. | 47.83% | 35.09% | 57.87% | 73.45% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 4 | 4 | 4 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.48 | -0.37 | -1.66 | -0.45 |
7 Days Ago | -0.48 | -0.37 | -1.66 | -0.45 |
30 Days Ago | -0.48 | -0.37 | -1.66 | -0.45 |
60 Days Ago | -0.44 | -0.27 | -1.39 | 0.12 |
90 Days Ago | -0.33 | -0.25 | -1.29 | 0.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.48 | -0.37 | -1.66 | -0.45 |
Zacks Consensus Estimate | -0.48 | -0.37 | -1.66 | -0.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.54 | -0.66 | -0.57 | -0.92 | NA |
Estimate | -0.40 | -0.34 | -0.64 | -0.81 | NA |
Difference | -0.14 | -0.32 | 0.07 | -0.11 | -0.13 |
Surprise | -35.00% | -94.12% | 10.94% | -13.58% | -32.94% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more